These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24516924)

  • 21. [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?].
    Volkova NI; Porksheyan MI
    Ter Arkh; 2017; 89(2):91-98. PubMed ID: 28393828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of socio-economic status in observational studies: A study model on non-alcoholic steato-hepatitis (NASH).
    Nobili V; Mosca A; Silano M; Agostoni C
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):209-211. PubMed ID: 30563736
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.
    Middleton JP; Wiener RC; Barnes BH; Gurka MJ; DeBoer MD
    Clin Pediatr (Phila); 2014 Dec; 53(14):1318-25. PubMed ID: 24477713
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fatty liver, alcoholic steatohepatitis, and non-alcoholic steatohepatitis].
    Bernal-Reyes R
    Rev Gastroenterol Mex; 2012 Aug; 77 Suppl 1():84-6. PubMed ID: 22939493
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease: Epidemiology, Assessments, and Interventions Entering 2021.
    Barritt AS
    Clin Ther; 2021 Mar; 43(3):436-437. PubMed ID: 33618858
    [No Abstract]   [Full Text] [Related]  

  • 26. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fructose as a risk factor nonalcoholic fatty liver disease].
    Yi C; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):383-5. PubMed ID: 25222975
    [No Abstract]   [Full Text] [Related]  

  • 28. Fructose and Nonalcoholic Fatty Liver Disease.
    Lustig RH
    J Calif Dent Assoc; 2016 Oct; 44(10):613-17. PubMed ID: 29035477
    [No Abstract]   [Full Text] [Related]  

  • 29. [Value of ANI in differentiating between alcoholic liver disease and nonalcoholic fatty liver disease].
    Wang J; Li P; Jiang Z; Yang Q; Liu Y; Shi R; Mi Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):136-9. PubMed ID: 26983484
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonalcoholic Fatty Liver Disease in Children: Where Are We?
    Li J; Cheung R
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2210-2215. PubMed ID: 35149222
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonalcoholic Fatty Liver Disease.
    Filipović B; Forbes A; Tepeš B; Dumitraşcu DL
    Can J Gastroenterol Hepatol; 2018; 2018():2097435. PubMed ID: 30155450
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease in children and adolescents.
    Nobili V
    Clin Biochem; 2014 Jun; 47(9):720. PubMed ID: 24854694
    [No Abstract]   [Full Text] [Related]  

  • 33. Expand SNAP to Reduce Nonalcoholic Fatty Liver Disease in the United States.
    Gundersen C
    J Nutr; 2020 Jan; 150(1):6-7. PubMed ID: 31603197
    [No Abstract]   [Full Text] [Related]  

  • 34. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE.
    Golovanova EV; Lazebnik LB
    Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why we need to curb the emerging worldwide epidemic of nonalcoholic fatty liver disease.
    Diehl AM; Farpour-Lambert NJ; Zhao L; Tilg H
    Nat Metab; 2019 Nov; 1(11):1027-1029. PubMed ID: 32694863
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!].
    Gillessen A
    MMW Fortschr Med; 2015 Jan; 157(1):69. PubMed ID: 25767868
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling.
    Chhatwal J; Tapper EB
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):280-282. PubMed ID: 35123079
    [No Abstract]   [Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease - a growing public health problem.
    Mikolašević I; Filipec Kanižaj T; Targher G
    Croat Med J; 2021 Feb; 62(1):1-3. PubMed ID: 33660954
    [No Abstract]   [Full Text] [Related]  

  • 39. Integration of public health measures for NAFLD into India's national programme for NCDs.
    Sarin SK; Prasad M; Ramalingam A; Kapil U
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):777-778. PubMed ID: 34509189
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease: today and tomorrow.
    Abenavoli L
    Rev Recent Clin Trials; 2014; 9(3):125. PubMed ID: 25600478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.